Jeff Haessler

10.0k total citations
16 papers, 1.0k citations indexed

About

Jeff Haessler is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Jeff Haessler has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Jeff Haessler's work include Multiple Myeloma Research and Treatments (13 papers), Protein Degradation and Inhibitors (5 papers) and Cancer therapeutics and mechanisms (3 papers). Jeff Haessler is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Protein Degradation and Inhibitors (5 papers) and Cancer therapeutics and mechanisms (3 papers). Jeff Haessler collaborates with scholars based in United States, United Kingdom and Netherlands. Jeff Haessler's co-authors include Bart Barlogie, John D. Shaughnessy, John Crowley, Elias Anaissie, Frits van Rhee, Joshua Epstein, Mauricio Pineda‐Roman, Maurizio Zangari, Ronald C. Walker and Tracy L. Brown and has published in prestigious journals such as Blood, Cancer and British Journal of Haematology.

In The Last Decade

Jeff Haessler

15 papers receiving 992 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff Haessler United States 11 861 666 521 98 68 16 1.0k
Anne‐Marie Stoppa France 19 1.2k 1.3× 756 1.1× 592 1.1× 141 1.4× 95 1.4× 54 1.4k
Dan Spoon United States 9 1.3k 1.5× 854 1.3× 671 1.3× 171 1.7× 56 0.8× 11 1.4k
Tommasina Guglielmelli Italy 13 710 0.8× 589 0.9× 441 0.8× 124 1.3× 78 1.1× 31 879
RA Kyle United States 12 540 0.6× 542 0.8× 297 0.6× 163 1.7× 44 0.6× 17 826
K Schiffman United States 8 605 0.7× 125 0.2× 456 0.9× 102 1.0× 95 1.4× 8 851
Silke Soucek Germany 15 655 0.8× 379 0.6× 225 0.4× 367 3.7× 23 0.3× 21 985
Cindy Varga United States 17 371 0.4× 519 0.8× 266 0.5× 170 1.7× 48 0.7× 60 746
Sosana Delimpasi Greece 12 509 0.6× 399 0.6× 364 0.7× 102 1.0× 37 0.5× 61 649
Jiří Minařík Czechia 14 472 0.5× 380 0.6× 277 0.5× 105 1.1× 54 0.8× 112 637
JF Rossi France 13 461 0.5× 292 0.4× 473 0.9× 99 1.0× 113 1.7× 22 927

Countries citing papers authored by Jeff Haessler

Since Specialization
Citations

This map shows the geographic impact of Jeff Haessler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Haessler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Haessler more than expected).

Fields of papers citing papers by Jeff Haessler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Haessler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Haessler. The network helps show where Jeff Haessler may publish in the future.

Co-authorship network of co-authors of Jeff Haessler

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Haessler. A scholar is included among the top collaborators of Jeff Haessler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Haessler. Jeff Haessler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Carty, Cara L., Samsiddhi Bhattacharjee, Jeff Haessler, et al.. (2014). Analysis of Metabolic Syndrome Components in >15 000 African Americans Identifies Pleiotropic Variants. Circulation Cardiovascular Genetics. 7(4). 505–513. 32 indexed citations
3.
Liu, Eric Yi, Steven Buyske, Aaron K. Aragaki, et al.. (2012). Genotype Imputation of MetabochipSNPs Using a Study‐Specific Reference Panel of ∼4,000 Haplotypes in African Americans From the Women's Health Initiative. Genetic Epidemiology. 36(2). 107–117. 29 indexed citations
4.
Shaughnessy, John D., Yiming Zhou, Jeff Haessler, et al.. (2009). TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3. British Journal of Haematology. 147(3). 347–351. 50 indexed citations
5.
Zhou, Yiming, Bijay Nair, John D. Shaughnessy, et al.. (2009). Cytogenetic abnormalities in multiple myeloma: poor prognosis linked to concomitant detection in random and focal lesion bone marrow samples and associated with high‐risk gene expression profile. British Journal of Haematology. 145(5). 637–641. 5 indexed citations
6.
Bartel, Twyla B., Jeff Haessler, Tracy L. Brown, et al.. (2009). F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood. 114(10). 2068–2076. 354 indexed citations
7.
Zangari, Maurizio, Frits van Rhee, Elias Anaissie, et al.. (2008). Eight‐year median survival in multiple myeloma after total therapy 2: roles of thalidomide and consolidation chemotherapy in the context of total therapy 1. British Journal of Haematology. 141(4). 433–444. 28 indexed citations
8.
Pineda‐Roman, Mauricio, Maurizio Zangari, Jeff Haessler, et al.. (2008). Sustained complete remissions in multiple myeloma linked to bortezomib in total therapy 3: comparison with total therapy 2. British Journal of Haematology. 140(6). 625–634. 125 indexed citations
9.
Barlogie, Bart, Jeff Haessler, Mauricio Pineda‐Roman, et al.. (2008). Completion of premaintenance phases in total therapies 2 and 3 improves clinical outcomes in multiple myeloma. Cancer. 112(12). 2720–2725. 10 indexed citations
10.
Xiong, Wei, Xiaosong Wu, Sadie Johnson, et al.. (2008). An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood. 112(10). 4235–4246. 106 indexed citations
11.
Johnson, David C., Sophie L. Corthals, Antje Hoering, et al.. (2008). Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping. Blood. 112(13). 4924–4934. 48 indexed citations
12.
13.
Barlogie, Bart, Mauricio Pineda‐Roman, Frits van Rhee, et al.. (2008). Thalidomide arm of Total Therapy 2 improves complete remission duration and survival in myeloma patients with metaphase cytogenetic abnormalities. Blood. 112(8). 3115–3121. 166 indexed citations
14.
15.
Morgan, Gareth J., David C. Johnson, John Crowley, et al.. (2006). The Genetic Contribution to the Aetiology of Thalidomide Associated VTE.. Blood. 108(11). 246–246. 1 indexed citations
16.
Ness, Brian G. Van, Suzanne Grindle, Antje Hoering, et al.. (2006). SNP Associations with Event Free Survival in Myeloma from Two Phase III Clinical Trials Using the Bank On A Cure Chip.. Blood. 108(11). 131–131.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Marie Stoppa Breakdown of academic impact, for papers by Dan Spoon Breakdown of academic impact, for papers by Tommasina Guglielmelli Breakdown of academic impact, for papers by RA Kyle Breakdown of academic impact, for papers by K Schiffman Breakdown of academic impact, for papers by Silke Soucek Breakdown of academic impact, for papers by Cindy Varga Breakdown of academic impact, for papers by Sosana Delimpasi Breakdown of academic impact, for papers by Jiří Minařík Breakdown of academic impact, for papers by JF Rossi
Rankless by CCL
2026